23 results
Thumbnail

D3.344 - Biological therapy for severe chronic spontaneous urticaria associated with autoimmune atrophic gastritis

Thumbnail

D3.348 - A Case of 19p13.3 Microdeletion

Thumbnail

D3.349 - Evaluation of natural killer cells in female infertility

Thumbnail

D3.351 - Characterization of peanut roasting-enhanced Ara h 2 - Ara h 1 complexes

Thumbnail

D3.345 - Blood Dendritic Cell Antigen 3-Positive Dendritic Cells Attenuate Th2 Responses in Allergic Rhinitis and Chronic Rhinosinusitis

Thumbnail

D3.346 - Impact of local craniocerebral hypothermia on inflammatory cytokine production in ischemic stroke

Thumbnail

D3.347 - AllergoOncology: a systematic review of the impact of glycosylation on IgE antibody structure function and mechanisms of disease

Thumbnail

D3.350 - Monocytic myeloid-derived suppressor cells (M-MDSCs) increase the expression of TIGIT on γδ T cells

Thumbnail

D3.353 - An EAACI Task Force Scoping Review: Human Monocytes and Macrophages in Allergy – Implications for AllergoOncology

Thumbnail

D3.354 - Selective IgE deficiency in children: its role in autoimmunity

Thumbnail

D3.355 - Decoupling of total IgE and peripheral blood eosinophilia in pancreatic ductal adenocarcinoma: preliminary study

Thumbnail

D3.356 - Unconventional T cells in leukocyte adhesion deficiency I (LAD-I)

Thumbnail

D1.90 - Remission of asthma on biological therapy: one center experience

Thumbnail

D1.98 - MV130 drives the differentiation of human monocytes into dendritic cells with antiallergic properties

Thumbnail

D1.102 - Md

Thumbnail

D1.88 - Mepolizumab and intestinal parasitic infection: A case report

Thumbnail

D1.91 - Baseline characteristics and main clinical outcomes of patients receiving tezepelumab in the framework of use in Special Situations prior to commercialization in Spain (T-ROSS Study)

Thumbnail

D1.92 - Results from the EGPAware Delphi study on Red Flags for Suspicion of Eosinophilic Granulomatosis with Polyangiitis (EGPA): current management in Europe

Thumbnail

D1.93 - ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up

Thumbnail

D1.94 - Impact of overweight and obesity on clinical remission and Response to Biologics in Severe Asthma Patients